In this issue:
MRAs in HF
Semaglutide for HFMREF/HFPEF
Qiliqiangxin in HFREF
Dapagliflozin and RV-pulmonary vascular interaction in HFPEF
Effect of sotagliflozin on health status in worsening HF
Haemocompatibility of apixaban in LVADs
p38α MAPK inhibition for LMNA-related dilated cardiomyopathy
2-year outcomes of atrial shunt device in HFPEF/HFMREF
Serum uric acid–estimated GFR ratio correlates with outcomes in elderly acute HF
Health coaching for caregivers of patients with chronic HF
Please login below to download this issue (PDF)